G. Ackermann

发表

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera

R. Buhmann, R. Henschler, R. Biemann, 2021, Journal of Clinical Virology Plus.

In Vitro Activity of OPT-80 against Clostridium difficile

A. Rodloff, G. Ackermann, B. Löffler, 2004, Antimicrobial Agents and Chemotherapy.

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera

R. Buhmann, R. Henschler, T. Kaiser, 2021, Journal of Clinical Virology Plus.

High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.

G. Ackermann, M. Waizmann, 2010, Journal of substance abuse treatment.

Pericarditis after Allogeneic Peripheral Blood Stem Cell Transplantation Caused by Legionella pneumophila (Non-serogroup 1)

U. Hegenbart, J. Hofmann, A. Rodloff, 2001, Infection.

Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.

A. Rodloff, Stuart H. Cohen, G. Ackermann, 2003, The Journal of antimicrobial chemotherapy.

Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008

M. Christner, H. Rohde, G. Ackermann, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

A case of Clostridium difficile-associated disease due to the highly virulent clone of Clostridium difficile PCR ribotype 027, March 2007 in Germany.

E. Kuijper, W. Witte, J. Weile, 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

One-step cloning and expression of Clostridium difficile toxin B gene (tcdB).

J. P. Henderson, J. Silva, S. Cohen, 2002, Molecular and cellular probes.

Chronic Factitious Illness Presenting as Munchausen's Gonarthritis

A. Rodloff, Reiner Schaumann, G. Ackermann, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.

A. Rodloff, Reiner Schaumann, J. Beer, 2004, The Journal of antimicrobial chemotherapy.

Therapeutic efficacy of moxifloxacin in a murine model of severe systemic mixed infection with Escherichia coli and Bacteroides fragilis.

A. Rodloff, Reiner Schaumann, G. Ackermann, 2003, Anaerobe.

OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review.

G. Ackermann, M. Gerber, 2008, Expert opinion on investigational drugs.

Mucosal-associated invariant T-Cell (MAIT) activation is altered by chlorpyrifos- and glyphosate-treated commensal gut bacteria

N. Jehmlich, M. von Bergen, J. Krause, 2020, Journal of immunotoxicology.

In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria.

E. Goldstein, A. Rodloff, Reiner Schaumann, 2000, International journal of antimicrobial agents.

Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.

A. Rodloff, G. Ackermann, 2003, The Journal of antimicrobial chemotherapy.

Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile.

C. Schmidt, G. Ackermann, B. Löffler, 2007, Diagnostic microbiology and infectious disease.

In Vitro Activities of Gatifloxacin, Two Other Quinolones, and Five Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria

A. Rodloff, Reiner Schaumann, M. Claros, 1999, Antimicrobial Agents and Chemotherapy.

Comparative Activity of Moxifloxacin in Vitro Against Obligately Anaerobic Bacteria

E. Goldstein, A. Rodloff, Reiner Schaumann, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

The Activation of Mucosal-Associated Invariant T (MAIT) Cells Is Affected by Microbial Diversity and Riboflavin Utilization in vitro

S. Müller, F. Schattenberg, N. Jehmlich, 2020, Frontiers in Microbiology.

Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.

U. Reischl, G. Ackermann, M. Gerber, 2008, Journal of medical microbiology.

OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review

G. Ackermann, M. Gerber, 2008 .

Resistance to Moxifloxacin in ToxigenicClostridium difficile Isolates Is Associated with Mutations in gyrA

A. Rodloff, P. Heisig, Stuart H. Cohen, 2001, Antimicrobial Agents and Chemotherapy.

Cloning and expression of Clostridium difficile toxin A gene (tcdA) by PCR amplification and use of an expression vector.

A. Rodloff, J. Silva, S. Cohen, 2004, Molecular and cellular probes.

Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea.

A. Rodloff, B. Ruf, Reiner Schaumann, 2005, Journal of medical microbiology.

Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea.

A. Rodloff, J. Silva, Stuart H. Cohen, 2001, Diagnostic microbiology and infectious disease.

Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile.

J. P. Henderson, A. Rodloff, J. Silva, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998.

J. P. Henderson, Stuart H. Cohen, Y. Tang-Feldman, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vitro activity of sitafloxacin against Clostridium difficile.

A. Rodloff, P. Heisig, J. Silva, 2001, The Journal of antimicrobial chemotherapy.

Prevalence of Enterotoxin Producing Staphylococcus aureus in Stools of Patients with Nosocomial Diarrhea

G. Ackermann, K. Flemming, 2007, Infection.

Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays

R. Biemann, G. Ackermann, C. Jassoy, 2022, Journal of Clinical Virology.

Infections Caused by Stenotrophomonas maltophilia– A Prospective Study

A. Rodloff, Reiner Schaumann, G. Ackermann, 2001, Infection.

Comparative In Vitro Activities of Gemifloxacin, Other Quinolones, and Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria

A. Rodloff, N. Kleinkauf, Reiner Schaumann, 2001, Antimicrobial Agents and Chemotherapy.

In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria.

A. Rodloff, Reiner Schaumann, M. Claros, 2000, The Journal of antimicrobial chemotherapy.

Electroporation of DNA sequences from the pathogenicity locus (PaLoc) of toxigenic Clostridium difficile into a non-toxigenic strain.

J. P. Henderson, A. Rodloff, J. Silva, 2001, Molecular and cellular probes.

Mapping of linear antigenic determinants on glycoprotein C of herpes simplex virus type 1 and type 2 recognized by human serum immunoglobulin G antibodies

J. Kühn, H. Eggers, U. Wieland, 1998, Journal of medical virology.